2 insiders reported 10 Form 4 transactions for Oncotelic Therapeutics, Inc. (OTLC) over the past 18 months (most recent 2026-07-02). Recent activity: Trieu Vuong (CHAIRMAN AND CEO) Buy 240,000 shares, Trieu Vuong (CHAIRMAN AND CEO) Buy 115,000 shares, Trieu Vuong (CHAIRMAN AND CEO) Buy 75,000 shares, Trieu Vuong (CHAIRMAN AND CEO) Buy 65,000 shares, Shah Amit B. (CFO) Buy 20,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Trieu Vuong | CHAIRMAN AND CEO | Buy | 240,000 | $10,344 |
| 2026-06-24 | Trieu Vuong | CHAIRMAN AND CEO | Buy | 115,000 | $5,175 |
| 2026-06-24 | Trieu Vuong | CHAIRMAN AND CEO | Buy | 75,000 | $3,375 |
| 2026-06-24 | Trieu Vuong | CHAIRMAN AND CEO | Buy | 65,000 | $2,925 |
| 2026-06-22 | Shah Amit B. | CFO | Buy | 20,000 | $1,000 |
| 2026-06-17 | Trieu Vuong | CHAIRMAN AND CEO | Buy | 239,759 | $10,693 |
| 2026-06-17 | Trieu Vuong | CHAIRMAN AND CEO | Buy | 96,000 | $4,320 |
| 2025-07-10 | Trieu Vuong | CHAIRMAN AND CEO | Buy | 104,000 | $1,040 |
| 2025-07-10 | Trieu Vuong | CHAIRMAN AND CEO | Buy | 1 | $0 |
| 2025-07-10 | Trieu Vuong | CHAIRMAN AND CEO | Buy | 94,736 | $947 |
Source: SEC Form 4 filings · as of 2026-07-02